Doctors issued a stark warning that routine over-the-counter painkillers could be driving a hidden crisis of hypertension and ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

The drug semaglutide, sold commercially as Ozempic or Wegovy, is well known for helping people lose significant amounts of weight quickly. Now the U.S. Food and Drug Administration has approved Wegovy ...

Trial results showing that a potent anti-obesity drug offers strong protection against serious heart problems have electrified researchers. They say that the findings could change how this and other ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Editor’s Note (3/8/24): Today the U.S. Food and Drug Administration approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular ...

Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...

Drugs that limit the activity of cells called neutrophils could make heart attacks less severe without compromising the ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

There’s mounting evidence that GLP-1 drugs have health benefits beyond diabetes and weight loss, for conditions ranging from addiction to Parkinson’s—and scientists are evolving theories of why. “Many ...